Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Probable propafenone-induced transient global amnesia

R J Jones1, S R Brace, E L Vander Tuin

  • 1Ohio Northern University, Ada 45810, USA.

The Annals of Pharmacotherapy
|June 1, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fracture-related hospitalisations in newly diagnosed high-risk localised or metastatic hormone-sensitive prostate cancer: secondary analysis of the STAMPEDE phase III trials of docetaxel and zoledronic acid using healthcare systems data.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Cancer Trial Impact: Understanding Implementation of the Short Course Oncology Treatment (SCOT) Trial Findings in colorectal cancer at a National Level.

Clinical oncology (Royal College of Radiologists (Great Britain))·2022
Same author

Using diffusion MRI data acquired with ultra-high gradient strength to improve tractography in routine-quality data.

NeuroImage·2021
Same author

Fermentative volatile fatty acid production and recovery from grass using a novel combination of solids separation, pervaporation, and electrodialysis technologies.

Bioresource technology·2021
Same author

Corrigendum to Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial: Ann Oncol 2019; 30: 1992-2003.

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Addition of docetaxel to hormonal therapy in low- and high-burden metastatic hormone sensitive prostate cancer: long-term survival results from the STAMPEDE trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

A case study suggests propafenone, an antiarrhythmic drug, may cause transient global amnesia. Symptoms resolved after discontinuing propafenone, indicating a potential rare side effect requiring patient monitoring.

Area of Science:

  • Pharmacology
  • Neurology
  • Cardiology

Background:

  • Propafenone is a Class 1C antiarrhythmic medication.
  • It functions by blocking fast sodium channels in cardiac and Purkinje fibers.
  • The drug also exhibits weak beta- and calcium-channel blockade.

Observation:

  • A 61-year-old male patient experienced amnesia and disorientation after six days of propafenone therapy.
  • These central nervous system symptoms resolved within 6-7 hours of drug discontinuation.
  • The patient had been prescribed propafenone for atrial fibrillation.

Findings:

  • This case suggests a probable link between propafenone and transient global amnesia.
  • Central nervous system effects, including confusion and amnesia, are known but rare adverse events associated with propafenone.

Related Experiment Videos

  • The rapid symptom resolution upon withdrawal supports propafenone as the causative agent.

    • Implications:

    • Clinicians should consider propafenone as a potential cause of amnesia in patients.
    • Monitoring for neurological side effects is crucial for patients on propafenone therapy.
    • This finding adds to the known adverse effect profile of propafenone, particularly its central nervous system impact.